Clinical trial
Study of Safety and Tolerability of Intravenous CRS-100 in Adults With Carcinoma…
NCT00327652 · Anza Therapeutics, Inc., Industry · Completed
Key facts
| NCT number | NCT00327652 |
|---|---|
| Title | Study of Safety and Tolerability of Intravenous CRS-100 in Adults With Carcinoma and Liver Metastases |
| Official title | Phase 1 Dose-Escalation Study of Safety and Tolerability of Intravenous CRS-100 in Adults With Carcinoma and Liver Metastases |
| Lead sponsor | Anza Therapeutics, Inc., Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Neoplasm Metastasis, Liver Neoplasms, Carcinoma |
| Intervention type | Drug |
| Interventions | CRS-100 |
| Enrollment | 9 |
| Start date | Oct 1, 2006 |
| Primary completion | Feb 1, 2008 |
| First posted | May 18, 2006 |
| Last update posted | Apr 24, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: